PUBLIC COMPANY
savePierre Fabre Pharmaceuticals Inc
updated 2mo ago
community read0 votes
pipeline
1
marketed
0
phase 3
0
catalysts ytd
0
approvals ytd
0
recalls ytd
0
Pipeline(1)
pipeline depth1 products
1Phase 2
Upcoming
no upcoming catalysts on record
Recent(90d)
nothing in the last 90 days
view all catalysts →Active trials
🐶 Hiring Signal
News
- Atara, Pierre Fabre's cell therapy to get another shot at FDA approvalThere's new life for a twice-rejected T cell therapy from Atara Biotherapeutics and Pierre Fabre Pharmaceuticals. US regulators are willing to reconsider using a Phase 3 study as the basis for an a…endpoints · 3mo ago
- STAT+: FDA to reconsider treatment for rare cancer after its surprise rejectionThe companies developing Ebvallo reached an agreement with the FDA to address its main reason for rejecting the drug.stat · 3mo ago
comments(0)
5-min edit window · permanent after that